Streetbeat News

Stock Prices

ULTA

Ulta Beauty (NASDAQ:ULTA) reported Q4 earnings of $8.08 per share, surpassing the $7.53 estimate, marking a 20.96% year-over-year increase. Sales reached $3.55B, exceeding the $3.53B estimate, up 10.13% from the previous year.

Portfolio Pulse from Happy Mohamed

March 14, 2024 | 8:06 pm

CODX

Co-Diagnostics (NASDAQ:CODX) reported Q4 2023 GAAP EPS of $(0.50), missing the $(0.20) estimate, with sales of $3.555M also missing the $3.625M estimate. Despite this, sales increased by 153.75% compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

March 14, 2024 | 8:05 pm

BTCUSD

A UK court dismissed Craig Wright's claim to be Satoshi Nakamoto, the creator of Bitcoin, in a lawsuit brought by the Crypto Open Patent Alliance (COPA). The ruling clarifies that Wright cannot legally identify himself as Nakamoto, reinforcing Bitcoin's anonymous and collective foundation. Bitcoin was trading at $71,055, down 2.5% over the past 24 hours.

Portfolio Pulse from Murtuza Merchant

March 14, 2024 | 8:05 pm

KOPN

Kopin Corporation (NASDAQ:KOPN) reported its Q4 earnings with a significant miss, posting an EPS of $-0.06 against an estimate of $-0.02, marking a -200.0% deviation. Revenue also saw a decrease, down $3.61 million from the same period last year. Despite a positive performance in the previous quarter, this report indicates a downturn in the company's financial health.

Portfolio Pulse from Benzinga Insights

March 14, 2024 | 8:05 pm

KOPN

Kopin Corporation (NASDAQ:KOPN) reported Q4 2023 earnings with a GAAP EPS of $(0.06), missing the $(0.04) estimate, and sales of $8.578M, missing the $9.029M estimate. This represents a 29.60% decrease in sales compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

March 14, 2024 | 8:03 pm

JNJ

LLY

MRK

WXXWY

WuXi AppTec and its affiliates face a setback as the Biotechnology Innovation Organization (BIO) cuts ties amid Congressional scrutiny over national security concerns. This decision affects U.S. industry giants like Eli Lilly, Merck, and Johnson & Johnson, all members of BIO. WuXi AppTec's shares fell significantly in Hong Kong and Shanghai, as did those of its sister companies, WuXi Biologics and WuXi XDC Cayman. The scrutiny stems from proposed bills aiming to restrict federal engagement with certain Chinese biotech firms. WuXi AppTec denies allegations related to national security risks.

Portfolio Pulse from Vandana Singh

March 14, 2024 | 8:03 pm

META

NVDA

PP

SPY

TSLA

Tesla Inc (TSLA) has become the worst-performing stock in the S&P 500 Index year-to-date in 2024, down 34.4%, amidst concerns of slower EV demand and production issues. Analysts have downgraded the stock and lowered price targets, with UBS cutting its price target from $225 to $165 and Wells Fargo from $200 to $125. The SPDR S&P 500 ETF Trust (SPY) is up 8.3% YTD, supported by the Magnificent 7 stocks, despite Tesla's underperformance. Other notable performers include Nvidia (NVDA) and Meta Platforms (META), with significant gains.

Portfolio Pulse from Chris Katje

March 14, 2024 | 8:02 pm

ELF

Investors have shown a bearish stance on e.l.f. Beauty (NYSE:ELF), with options trading indicating a split sentiment of 30% bullish and 69% bearish. Uncommon options trades were spotted, with a notable volume in calls over puts. The targeted price range for ELF over the last 3 months is between $100.0 to $270.0. Currently, ELF's stock price is up by 0.77% at $208.0, with analysts giving an average target price of $223.0. The RSI suggests ELF may be approaching overbought territory.

Portfolio Pulse from Benzinga Insights

March 14, 2024 | 8:01 pm

OC

Owens-Corning (NYSE:OC) has significantly outperformed the market with an annualized return of 27.14% over the past 5 years, turning a $100 investment into $328.04 today. The company's market capitalization stands at $14.12 billion.

Portfolio Pulse from Benzinga Insights

March 14, 2024 | 8:00 pm

VRT

Vertiv Hldgs (NYSE:VRT) has significantly outperformed the market with an annualized return of 49.31% over the past 5 years, growing a $1000 investment to $7,413.41. The company now has a market capitalization of $28.13 billion.

Portfolio Pulse from Benzinga Insights

March 14, 2024 | 8:00 pm